LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
University of Bordeaux
Burdeos, FranciaPublicaciones en colaboración con investigadores/as de University of Bordeaux (14)
2023
2022
2019
-
Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum
Cells, Vol. 8, Núm. 9
-
Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia
International Review of Neurobiology (Academic Press Inc.), pp. 259-279
2018
-
5-HT2A receptors in the basal ganglia
Receptors (Humana Press Inc.), pp. 273-310
-
D5 dopamine receptors control glutamatergic AMPA transmission between the motor cortex and subthalamic nucleus
Scientific Reports, Vol. 8, Núm. 1
-
GAT-3 Dysfunction Generates Tonic Inhibition in External Globus Pallidus Neurons in Parkinsonian Rodents
Cell Reports, Vol. 23, Núm. 6, pp. 1678-1690
2017
-
Impairment of serotonergic transmission by the antiparkinsonian drug L-DOPA: Mechanisms and clinical implications
Frontiers in Cellular Neuroscience
2016
-
L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
European Neuropsychopharmacology, Vol. 26, Núm. 8, pp. 1297-1309
-
The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
British Journal of Pharmacology, pp. 2135-2146
2013
-
Calcium as main trigger of mitochondrial oxidant stress in Parkinson's disease
Movement Disorders
-
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism
Journal of Neuroscience, Vol. 33, Núm. 36, pp. 14331-14341
2012
-
Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease
Journal of Physiology, Vol. 590, Núm. 22, pp. 5861-5875
2010
-
Regulation of subthalamic neuron activity by endocannabinoids
Synapse, Vol. 64, Núm. 9, pp. 682-698